NanoViricides, Inc.
NNVC
$1.13
-$0.01-0.88%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 38.69% | -14.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.29% | -15.07% | |||
| Operating Income | -24.29% | 15.07% | |||
| Income Before Tax | -24.40% | 14.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.40% | 14.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.40% | 14.83% | |||
| EBIT | -24.29% | 15.07% | |||
| EBITDA | -26.22% | 14.87% | |||
| EPS Basic | -7.08% | 19.31% | |||
| Normalized Basic EPS | -7.04% | 19.38% | |||
| EPS Diluted | -7.08% | 19.31% | |||
| Normalized Diluted EPS | -7.04% | 19.38% | |||
| Average Basic Shares Outstanding | 16.20% | 5.57% | |||
| Average Diluted Shares Outstanding | 16.20% | 5.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||